Brian Adams - Dec 31, 2021 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
General Counsel
Signature
/s/ Brian Adams
Stock symbol
RLAY
Transactions as of
Dec 31, 2021
Transactions value $
$17,174
Form type
4
Date filed
1/7/2022, 04:15 PM
Previous filing
Dec 27, 2021
Next filing
Jan 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Award $17.2K +658 +2.63% $26.10 25.6K Dec 31, 2021 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.
F2 In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 31, 2021.
F3 Includes 12,895 shares underlying RSUs.